Trial intelligence / Profile preview

Fenticonazole nitrate suppository vs miconazole nitrate for vulvovaginal candidiasis

CTR20130309Phase 2Active

Sponsor
Beijing Medicon Pharmaceutical Technology
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fenticonazole in vulvovaginal candidiasis (VVC), sponsored by Beijing Medicon Pharmaceutical Technology. Started Aug 2014; status: active.

02

Drugs

fenticonazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20130309.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130309.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call